Gonzalo Fernández-Miranda

CEO and Co-Founder at CureAge Therapeutics

Speaker

Gonzalo is a biotech entrepreneur and innovator specializing in advanced therapies, genetic medicines, and nanoparticle-based drug delivery. He is co-founder of three biotech companies (Ninevah Ltd, Nanobots SL, and CureAge Ltd) focused on developing next-generation genetic therapies. Gonzalo holds a PhD in Molecular Biology and is currently CEO of CureAge, a venture co-founded with Deep Science Ventures and the Children’s Tumor Foundation. CureAge is developing LNP-DNA delivery strategies to create the first curative treatments for Neurofibromatosis and other peripheral nerve diseases.